By Mrs Kendal Jane Chidwick

Journal articles

Chidwick K; Bharat C; Gisev N; Havard A; Camacho X; Pearson SA; Degenhardt L, 2025, 'Trends in prescription opioid analgesic use in Australia from 2015 to 2022', International Journal of Drug Policy, 135, http://dx.doi.org/10.1016/j.drugpo.2024.104666

Gillies MB; Chidwick K; Bharat C; Camacho X; Currow D; Gisev N; Degenhardt L; Pearson SA, 2024, 'Long-term prescribed opioid use after hospitalization or emergency department presentation among opioid naïve adults (2014–2020)—A population-based descriptive cohort study', British Journal of Clinical Pharmacology, 90, pp. 2111 - 2123, http://dx.doi.org/10.1111/bcp.16093

Bharat C; Chidwick K; Gisev N; Farrell M; Ali R; Degenhardt L, 2024, 'Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022', International Journal of Drug Policy, 123, http://dx.doi.org/10.1016/j.drugpo.2023.104255

Ahmed S; Pollack A; Havard A; Pearson SA; Chidwick K, 2023, 'Agreement of acute serious events recorded across datasets using linked Australian general practice, hospital, emergency department and death data: implications for research and surveillance', International Journal of Population Data Science, 8, http://dx.doi.org/10.23889/ijpds.v8i1.2118

Chidwick K; Pollack A; Busingye D; Norman S; Grulich A; Bavinton B; Guy R; Medland N, 2022, 'Utilisation of pre-exposure prophylaxis (PrEP) for HIV prevention in the Australian general practice setting: a longitudinal observational study', Sexual Health, 19, pp. 101 - 111, http://dx.doi.org/10.1071/SH21207

Pollack A; Busingye D; Thistlethwaite J; Blogg S; Chidwick K, 2022, 'Characteristics of patients aged 50-74 years with a request for an immunochemical faecal occult blood test in the Australian general practice setting', Australian Health Review, 46, pp. 222 - 232, http://dx.doi.org/10.1071/AH21129

Chidwick K; Myton R; Rodgers A; Jun M; Dartnell J; Balcomb A; Dore G, 2022, 'A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP-HEPC trial)', Journal of Viral Hepatitis, 29, pp. 135 - 146, http://dx.doi.org/10.1111/jvh.13629

Daniels B; Havard A; Myton R; Lee C; Chidwick K, 2022, 'Evaluating the accuracy of data extracted from electronic health records into MedicineInsight, a national Australian general practice database', International Journal of Population Data Science, 7, http://dx.doi.org/10.23889/IJPDS.V7I1.1713

Havard A; Manski-Nankervis JA; Thistlethwaite J; Daniels B; Myton R; Tu K; Chidwick K, 2021, 'Validity of algorithms for identifying five chronic conditions in MedicineInsight, an Australian national general practice database', BMC Health Services Research, 21, pp. 551, http://dx.doi.org/10.1186/s12913-021-06593-z

Busingye D; Daniels B; Brett J; Pollack A; Belcher J; Chidwick K; Blogg S, 2021, 'Patterns of real-world opioid prescribing in Australian general practice (2013-18)', Australian Journal of Primary Health, 27, pp. 416 - 424, http://dx.doi.org/10.1071/PY20270

Busingye D; Chidwick K; Simpson V; Dartnell J; J Dore G; Balcomb A; Blogg S; Dore G, 2021, 'The changing characteristics of patients with chronic hepatitis C prescribed direct acting antiviral medicines in general practice since listing of the medicines on the Australian Pharmaceutical Benefits Scheme', JGH Open, 5, pp. 813 - 819, http://dx.doi.org/10.1002/jgh3.12593

de Oliveira Costa J; Gianacas C; Beard F; González-Chica DA; Chidwick K; Osman R; MacIntyre CR; Havard A, 2021, 'Cumulative annual coverage of meningococcal B vaccination in Australian general practice for three at-risk groups, 2014 to 2019', Human Vaccines & Immunotherapeutics, pp. 1 - 10, http://dx.doi.org/10.1080/21645515.2021.1923349

Busingye D; Pollack A; Chidwick K, 2021, 'Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study', PLoS ONE, 16, pp. e0252458, http://dx.doi.org/10.1371/journal.pone.0252458

Belcher J; Myton R; Yoo J; Boville C; Chidwick K, 2021, 'Exploring the physical health of patients with severe or long-term mental illness using routinely collected general practice data from MedicineInsight', Australian Journal of General Practice, 50, pp. 944 - 951, http://dx.doi.org/10.31128/AJGP-08-20-5563

Schaffer AL; Busingye D; Chidwick K; Brett J; Blogg S, 2021, 'Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study', BJGP Open, 5, pp. 1 - 10, http://dx.doi.org/10.3399/bjgpopen20X101120

Chidwick K; Busingye D; Pollack A; Osman R; Yoo J; Blogg S; Rubel D; Smith S, 2020, 'Prevalence, incidence and management of atopic dermatitis in Australian general practice using routinely collected data from MedicineInsight', Australasian Journal of Dermatology, 61, pp. e319 - e327, http://dx.doi.org/10.1111/ajd.13268

Totterdell J; Phillips A; Glover C; Chidwick K; Marsh J; Snelling T; Macartney K, 2020, 'Safety of live attenuated herpes zoster vaccine in adults 70–79 years: A self-controlled case series analysis using primary care data from Australia's MedicineInsight program', Vaccine, 38, pp. 3968 - 3979, http://dx.doi.org/10.1016/j.vaccine.2020.03.054

Busingye D; Gianacas C; Pollack A; Chidwick K; Merrifield A; Norman S; Mullin B; Hayhurst R; Blogg S; Havard A; Stocks N, 2019, 'Data Resource Profile: MedicineInsight, an Australian national primary health care database', International Journal of Epidemiology, 48, pp. 1741 - 1741H, http://dx.doi.org/10.1093/ije/dyz147

Chidwick K; Strongman H; Matthews A; Stanway S; Lyon AR; Smeeth L; Bhaskaran K, 2018, 'Statin use in cancer survivors versus the general population: Cohort study using primary care data from the UK clinical practice research datalink', BMC Cancer, 18, pp. 1018, http://dx.doi.org/10.1186/s12885-018-4947-8

Chidwick K; Kiss D; Gray R; Yoo J; Aufgang M; Zekry A, 2018, 'Insights into the management of chronic hepatitis C in primary care using MedicineInsight', Australian journal of general practice, 47, pp. 639 - 645, http://dx.doi.org/10.31128/AJGP-02-18-4482

Illingworth PJ; Lahoud R; Quinn F; Chidwick K; Wilkinson C; Sacks G, 2014, 'Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment', Patient Preference and Adherence, 8, pp. 813 - 826, http://dx.doi.org/10.2147/PPA.S58046

Conference Papers

Havard A; Chidwick K; Daniels B; Thistlethwaite J; Myton R; Blogg S; Wall M; Quick L; Pollack A; Manski-Nankervis J-A, 2021, 'Validity of algorithms for identifying five chronic conditions in MedicineInsight, Australian national primary care data', in INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, OXFORD UNIV PRESS, http://dx.doi.org/10.1093/ije/dyab168.270

Conference Posters

Chidwick K, 2024, 'Long-term prescribed opioid use after hospitalisation or emergency department presentation among opioid-naïve adults in New South Wales (NSW), Australia (2014–2020)—a population-based cohort study', Wesley Conference Centre, Sydney NSW, presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024

Chidwick K, 2024, 'Trends in prescription opioid analgesic use in Australia from 2015 to 2022: a national analysis using pharmaceutical claims and sales data', Wesley Conference Centre, Sydney NSW, presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024

Conference Presentations

Chidwick K, 2024, 'Trends in prescription opioid analgesic use in Australia from 2015 to 2022: a national analysis using pharmaceutical claims and sales data', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=vxBO7_cTwPU&t=330s

Reports

Chidwick K; Bharat C; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Real-world dosing intervals of long-acting buprenorphine for opioid agonist treatment., UNSW Sydney, Sydney, 345, http://dx.doi.org/10.26190/ayet-f348, https://ndarc.med.unsw.edu.au/resource/real-world-dosing-intervals-long-acting-buprenorphine-opioid-agonist-treatment

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in New South Wales, 2013-2022, UNSW Sydney, Sydney, 347, http://dx.doi.org/10.26190/rzmn-a864, https://ndarc.med.unsw.edu.au/resource/nsw-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Queensland, 2013-2022, UNSW Sydney, Sydney, 349, http://dx.doi.org/10.26190/ybm1-3f83, https://ndarc.med.unsw.edu.au/resource/qld-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in South Australia, 2013-2022, UNSW Sydney, Sydney, 350, http://dx.doi.org/10.26190/y21d-yd24, https://ndarc.med.unsw.edu.au/resource/sa-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Tasmania, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 351, http://dx.doi.org/10.26190/q6zj-fx75, https://ndarc.med.unsw.edu.au/resource/tas-trends-use-opioid-agonist-treatment-australia-2013-2022

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Australian Capital Territory, 2013-2022, UNSW Sydney; NDARC, Sydney, 346, http://dx.doi.org/10.26190/16m9-6z16, https://ndarc.med.unsw.edu.au/resource/ndarc-technical-reports-345-353

Bharat C; Chidwick K; Gisev N; Farrell M; Degenhardt L, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in the Northern Territory, 2013-2022, UNSW Sydney, Sydney, 348, http://dx.doi.org/10.26190/mt8r-kd57, https://ndarc.med.unsw.edu.au/resource/nt-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Victoria, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 352, http://dx.doi.org/10.26190/gjpp-py45, https://ndarc.med.unsw.edu.au/resource/vic-trends-use-opioid-agonist-treatment-australia-2013-2022

Chidwick K; Gisev N; Degenhardt L; Farrell M; Bharat C, 2023, NDARC Technical Report: Trends in the use of Opioid Agonist Treatment in Western Australia, 2013-2022, UNSW Sydney; National Drug and Alcohol Research Centre, Sydney, 353, http://dx.doi.org/10.26190/ftbz-w461, https://ndarc.med.unsw.edu.au/resource/wa-trends-use-opioid-agonist-treatment-australia-2013-2022

Back to profile page